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A B S T R A C T
Medicinal plants and their botanical formulations have gained a pivotal attention among scientiﬁc researchers
mainly due to its action as health promoters. Licorice (Glycyrrhiza glabra L.) constitutes a great example, with an
increasingly evidenced antimicrobial potential. Opportunistic yeast infections constitute an alarming public
health problem, highly exacerbated by the ineﬃcacy of antifungal drugs and the increase of drug-resistant
microorganisms, being Candida species one of the most common invaders. The present work aims to assess
Candida glabrata and Candida albicans susceptibility to G. glabramethanol: water extract by using ﬂow cytometry
and transmission electron microscopy techniques. After 5 min, licorice extract (1.5 mg/mL) altered Candida
membrane potential. Within an hour, it induced primary damages on Candida species cells, causing cell cyto-
plasm disorganization with high evidence of cell membrane invaginations, making cells turgid. Thus, based on
the current ﬁndings, licorice extract seems to be a promising anti-Candida agent, without presenting any toxic
potential at the eﬀective concentrations used.
1. Introduction
Medicinal plants have gained a special attention in the last years. In
fact, natural matrices possess a multitude of health beneﬁts (Faria et al.,
2011; Lopes et al., 2013; Sher, 2009). Particularly, the study of the
antifungal and anti-yeast properties against opportunistic fungi and
yeasts, such as Candida species, is still being the focus of numerous
researches (Martins et al., 2015b, 2014). Considered a commensal mi-
croorganism, being naturally present in gastrointestinal and genitour-
inary tracts of healthy population, Candida species have been increas-
ingly associated with severe organic dysfunctions (Martins et al., 2014).
As the fourth leading cause of systemic infections, they have markedly
triggering the wellbeing involve in life-threatening situations (Martins
et al., 2014).
Nowadays, there is a lack of antifungal agents with recognized ef-
ﬁciency, becoming urgent to provide a proper and eﬃcient clinical
intervention. Despite at several years ago these drugs exerted a potent
eﬀect, presently they are no longer eﬀective (Martins et al., 2015b). In a
general manner, microorganisms have shown increasing rates of drug
resistance, and Candida species comprises a very good example (Martins
et al., 2015b). Aiming to control/avert this emerging epidemic pro-
blem, numerous studies have been carried out to evaluate the acquired
mechanisms of drug-resistance by Candida species, and to provide new
insights to the candidiasis treatment (Jiang et al., 2014; Kanafani and
Perfect, 2008; Perlin, 2009; Sanglard and Odds, 2002). However, be-
sides the evaluation of an eﬃcient multi-drug therapy, by using che-
micals drugs or even natural products combination, the assessment of
the corresponding mechanisms of action, the occurrence of morpholo-
gical changes in Candida cells and the determination of kinetic para-
meters are also important. All these achievements will provide knowl-
edge related with the type of cellular lesion occurred in Candida cells, to
infer the relevance and interest of licorice extract for future applica-
tions, as also to analyze the feasibility to carry out more detailed stu-
dies, such as the assessment of in vitro and in vivo cytotoxic potential in
human cells. Then, it will become possible to predict the in vivo safety
and upcoming clinical use of the studied substances and the likelihood
of side eﬀects occurrence, both at short and middle-long terms.
Considering the previous results obtained to licorice extract (com-
pletely characterized in terms of phenolic composition), namely anti-
oxidant (Martins et al., 2015a) and anti-Candida (Martins et al., 2016)
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activities, the present study aims to access the eﬀect of licorice extract
on cell integrity and cultivability of the most problematic and virulent
Candida species, namely Candida albicans and Candida glabrata species
(Martins et al., 2015c). The main aspects that triggered the develop-
ment of this experiment was to understand in which manner licorice
exerted its anti-Candida potential, once no visible eﬀects were observed
when isolated phenolic compounds present in the extract were tested
separately, while with the whole extract a prominent eﬀect was
reached. Cell changes occurred after licorice application was assessed
by ﬂow cytometry and transmission electron microscopy.
2. Material and methods
2.1. Plant material and phenolic extracts
Glycyrrhiza glabra L. rhizomes and roots, supplied by Soria Natural
(Garray− Soria, Spain), were obtained in autumn 2012, after reaching
three years. Methanol: water extraction of licorice was performed by
stirring the sample (1 g) with 30 mL of methanol/water (80:20, v/v) at
25 °C and 150 rpm for 1 h, and ﬁltered through Whatman no. 4 paper.
The obtained residue was again extracted with an additional 30 mL
portion of the extraction solvents mixture. Then, combined extracts
were evaporated at 35 °C under reduced pressure (rotary evaporator
Büchi R-210, Flawil, Switzerland) to remove the entire methanol used
to perform phenolic extraction, and subsequently lyophilized (FreeZone
4.5, Labconco, Kansas City, MO, USA). Finally, the lyophilized extracts
were re-dissolved in water, performing a stock solution with a con-
centration of 50 mg/mL, from which several dilutions were prepared
(Martins et al., 2015a).
The concentration tested in this study (1.5 mg/mL) was based on
the obtained results for minimal inhibitory (MIC) and minimal fungi-
cidal (MFC) concentrations (Martins et al., 2016), and prepared from a
licorice stock solution of 50 mg/mL. Sterile water was used as solvent.
2.2. Standards and reagents
Sabouraud Dextrose Broth (SDB) and Agar were from Merck
(Darmstadt, Germany). Propidium iodide (PI) cell dye and HyClone
Dulbecco's modiﬁed eagles medium (DMEM) were from Thermo Fisher
Scientiﬁc (Wilmington, USA). Hank's balanced salt solution (HBSS),
fetal bovine serum (FBS) and penicillin/streptomycin solution (100 U/
mL and 100 mg/mL, respectively) were purchased from Gibco
Invitrogen Life Technologies (California, USA). Water was treated in a
Milli-Q water puriﬁcation system (TGI Pure Water Systems, Greenville,
SC, USA).
2.3. Yeast strains
In this study two diﬀerent Candida species from the American Type
Culture Collection (ATCC) were selected, namely Candida albicans
ATCC 90028 and C. glabrata ATCC 2001 strains. The licorice extract
concentration (1.5 mg/mL) was selected taking into consideration the
previous results obtained (Martins et al., 2016) on the assessment of the
anti-Candida activity in planktonic and their respective bioﬁlms cells: C.
albicans ATCC 90028 (MIC/MFC≥ 1.5 mg/mL), C. glabrata ATCC 2001
(MIC = 0.75 mg/mL; MFC = 1.5 mg/mL). Both strains were from the
archive collection of the bioﬁlm group of the Centre of Biological En-
gineering, University of Minho, Braga − Portugal.
2.4. Assessment of licorice anti-Candida mechanism of action
To perform the assessment of the eﬀective mode of action of licorice
extract on Candida species, a standard concentration of 1.5 mg/mL was
used, based on the results obtained in the previous study (Martins et al.,
2016).
2.4.1. Cytometry experiments
2.4.1.1. Staining procedures for ﬂow cytometry experiments. The
ﬂuorescence probe PI was used to access the occurrence of cell
membrane lesions in Candida species. Thus, two colonies from the
sabouraud dextrose agar (SDA) were grown in SDB at 37 °C, 150 rpm,
until late exponential growth phase and collected by centrifugation
(2655g, for 5 min). Pellets were resuspended in water and the cell
concentration adjusted to a ﬁnal density of 0.5 McFarland, and then
incubated with 1.5 mg/mL licorice methanol: water extract for 5, 15,
30 and 60 min, without agitation, at 37 °C. After this time, Candida cells
were collected by centrifugation, resuspended in water and stained with
1 μg PI/mL in the dark, during 30 min. Positive (i.e. cells treated with
ethanol 90%) and negative (i.e. cells without licorice methanol: water
extract) controls were also included.
The staining cells were acquired in a FACSCalibur Cytometer (BD
Biosciences, Sydney) standard model equipped with 3 photo-
multiplayers (PMTs), standard ﬁlters (FL1: BP 530/30 nm; FL2: BP
585/42 nm; FL3: LP 650 nm) and a 15 mW 488 nm Argon Laser. Then,
Candida cells were analyzed and the percentage of stained cells was
determined, by using cell Quest Pro software (version 4.0.2, BD
Biosciences, Sydney).
2.4.1.2. Assessment of kinetic curves. Parallel to ﬂow cytometry
approaches, kinetic growth studies were also performed, by
cultivability assay methodology after treating Candida cells with
licorice extract, for 5, 15, 30 and 60 min, at 37 °C. Thus, at
predetermined time points, serial dilutions of yeasts suspensions were
prepared and plated on SDA medium for colony-forming units (CFU)
determination. Following incubation at 37 °C for 24 h, the number of
CFU was determined and results presented as Log reduction (CFUs/mL)
– Log reduction = log10 (number of viable cells before treatment) –
log10 (number of viable after treatment).
2.4.2. Transmission electron microscopy (TEM)
The eﬀect of licorice extract on Candida cells morphological struc-
ture was observed by transmission electron microscopy (TEM). For that,
Candida cells treated with 1.5 mg/mL of licorice extract during 30 min,
were prepared as described in previously section (2.4.1.1.) In brief,
samples were ﬁxed in 2.5% glutaraldehyde (Electron Microscopy sci-
ences, Hatﬁeld, USA) and 2% paraformaldehyde (Merck, Darmstadt,
Germany) in phosphate buﬀer 0.1 M with 0.5 mM MgCl2 (pH 6.5),
dehydrated and embedded in Epon resin (TAAB, Berks, England).
Ultrathin sections (40–60 nm thickness) were prepared on a RMC
Ultramicrotome (PowerTome, USA) using diamond knives (DDK,
Wilmington, DE, USA). The sections were mounted on 200 mesh copper
or nickel grids, stained with uranyl acetate and lead citrate for 5 min
each, and examined under a JEOL JEM 1400 TEM (Tokyo, Japan).
Images were digitally recorded using a CCD digital camera Orious
1100W Tokyo, Japan at the HEMS/I3S from the University of Porto.
ImageJ software (Rasband, 2017) was used to measure cell walls of
untreated and treated Candida cells. For that, ﬁve diﬀerent cells derived
from diﬀerent micrographs were measured in ﬁve diﬀerent cell wall
regions.
2.5. Evaluation of the cytotoxic activity
Liver tissues were rinsed in Hank's balanced salt solution containing
100 U/mL of penicillin and 100 μg/mL of streptomycin, and subse-
quently divided into 1 × 1 mm3 explants. Some explants were placed in
25 cm3 tissue ﬂasks, containing DMEM and supplemented with 10%
fetal bovine serum, 2 mM of non-essential amino acids, 100 U/mL of
penicillin and 100 mg/mL of streptomycin, and then incubated at 37 °C
with a humidiﬁed atmosphere containing 5% CO2. This medium was
replaced every 2 days, and cells cultivation continued under direct
monitoring every 2–3 days using a phase contrast microscope. Prior to
conﬂuence, cells were sub-cultured and plated in 96-well plates, with a
N. Martins et al. Industrial Crops & Products 108 (2017) 480–484
481
ﬁnal density of 1.0 × 104 cells/well and cultivated in DMEM medium,
containing 10% FBS, 100 U/mL of penicillin and 100 μg/mL of strep-
tomycin (Abreu et al., 2011). Then, cells were treated for 48 h with the
diﬀerent diluted sample solutions. Three independent experiments were
carried out and the results expressed in GI50 values (mg/mL), i.e. the
extract concentration that inhibited 50% of net cell growth. Ellipticine
was used as positive control.
2.6. Statistical analysis
All statistical tests were performed using IBM SPSS Statistics for
Windows, version 22.0. Means were compared using Tukey’s honestly
signiﬁcant diﬀerence (HSD) multiple comparisons test and further
coupled to Welch to verify the equality of means.
3. Results and discussion
Candida species are responsible for several opportunistic disorders
in human, which are diﬃcult to treat mostly due to their increasing
resistance to antifungals (Martins et al., 2015b). Therefore, it is very
important to search and to develop eﬃcient antifungal agents. Con-
sidering the highly eﬀective in vitro anti-Candida activity evidenced by
licorice methanol: water extract in previous experiments (Martins et al.,
2016) and that the mechanism of action of this plant extract is poorly
understood, it becomes essential to deepen knowledge on biocidal ef-
fect of licorice. In this sense, reference strains from C. albicans and C.
glabrata species were selected to determine the eﬀect of licorice extract
on its cells by ﬂow cytometry and transmission electron microscopy.
For that, a standard concentration of licorice extract was tested based
on the previous results (Martins et al., 2016) and the biocidal eﬀect
evaluated by ﬂow cytometry (Table 1 and Fig. 1).
Flow Cytometry has been used to determine the quantitative prop-
erties of single cells, measuring cell size, cell granularity, the amounts
of cell components, among other aspects in living cells, in less than one
minute. With the use of ﬂuorescent probes, ﬂow cytometry allows to
distinguish living from dead cells, to infer about membrane integrity
and other indicators of microbial viability. The monitoring of trans-
membrane electrochemical potential and membrane damages provides
rapid and feasible indications of the antimicrobial-agent-induced injury
(Gokahmetoglu et al., 2003). For this reason, this technique has been
markedly highlighted by several authors as a rapid and sensitive in vitro
method for anti-yeasts susceptibility assessment on diﬀerent Candida
species isolates (Gokahmetoglu et al., 2003). This assay was based on
the detection of increased permeability of Candida cells to PI, after li-
corice extract application.
After 5 min-licorice applications, nearly to 97% of C. glabrata ATCC
2001 were already PI stained (Table 1 and Fig. 1B). The eﬀect of li-
corice extract on C. albicans cells (Table 1 and Fig. 1A) is relatively
lower than that observed for C. glabrata cells, with a 70% of PI stained
cells after 5 min and no pronounced alterations after 10 (73%), 15
(77%), 30 (79%) and 60 min (81%) of licorice application. This sug-
gests that the loss of cell integrity due to the licorice extract is not time
dependent and the eﬀects are evident immediately after application.
Moreover, the fact that the cell damage to be more pronounced in C.
glabrata cells, comparatively to C. albicans might be related with the
diﬀerent levels of complexity between Candida species, displaying C.
albicans a more complex cellular envelope than C. glabrata species
(Groot et al., 2008).
Previous experiments carried out by Gokahmetoglu et al., 2003,
aiming at assessing the in vitro antifungal susceptibility of C. albicans to
ﬂuconazole and amphotericin B using ﬂow cytometry observed an in-
creasing resistance of Candida species to both anti-yeast drugs. The
authors stated that were necessary at least 24-h incubation for reading
microdilution assays, while to observe noticeable cell membrane da-
mages by ﬂow cytometry were required 4- and 2-h incubation, re-
spectively, to ﬂuconazole and amphotericin B (Gokahmetoglu et al.,
2003). Moreover, MIC value corresponded to the lowest drug con-
centration used, 1 μg/mL and 0.25 μg/mL respectively, that resulted in
an increase of mean channel ﬂuorescence by 80 and>90% of the
growth control for ﬂuconazole and amphotericin B (Gokahmetoglu
Table 1
Kinetic study of the candidacidal potential of licorice extract against Candida albicans ATCC 90028 and Candida glabrata ATCC 2001 strains by ﬂow cytometry using propidium iodide
staining.
Candida species Licorice extract (mg/mL) % of stained cells
(−) Control (+) Control 5 min. 10 min. 15 min. 30 min. 60 min.
C. albicans ATCC 90028 1.5 7.7 83.1 70.0 73.5 76.8 78.6 81.3
C. glabrata ATCC 2001 1.5 4.8 88.9 97.2 97.6 98.4 98.8 98.9
(−) Control – negative control, i.e. cells without licorice treatment; (+) Control – positive control, i.e. cells treated with ethanol 90%.
Fig. 1. Flow cytometry scattergram obtained to Candida albicans ATCC 90028 (A) and Candida glabrata ATCC 2001 (B), before (viable cells) and after 5′, 15′ and 30′ treatment with
licorice methanol: water extract; % corresponds to the% of PI stained cells.
N. Martins et al. Industrial Crops & Products 108 (2017) 480–484
482
et al., 2003). Interestingly, in this study after 5 min of licorice appli-
cation at 1.5 mg/mL, 70% of C. albicans ATCC 90028 cells presented
their cell membrane compromised, while after 60 min nearly to 81%
and 99% of C. albicans ATCC 90028 and C. glabrata ATCC 2001 strains
were already stained with PI, respectively. These results show that this
extract does not require the high exposing time that is reported for the
treatments with the traditional antifungals (Martins et al., 2015c).
Based on these ﬁndings, licorice extract seems to cause serious
primary cellular damages on Candida cells, once the passage of PI into
the cells occurred in a fast and signiﬁcant manner from the ﬁrst mo-
ments, being this aspect indicative of the existence of membrane da-
mages/lesions. In fact, after membrane destabilization, cells lack its
proper homeostasis, and consequently, organic unbalance blocks its
metabolic functions and cells lost functionality (Li et al., 2014;
Sanglard, 2002). Notwithstanding, it is also convenient to highlight that
in several cases, cells may only suﬀer reversible damages, and subse-
quently can adapt and re-acquire its functionality. Aiming to evaluate if
cell membrane integrity would aﬀect cultivability, the number of CFUs
was determined. Fig. 2A shows the CFU reduction of C. albicans ATCC
90028 and C. glabrata ATCC 2001 strains, treated with licorice extract
(1.5 mg/mL) over time. With our results, it is possible to conclude that
licorice extract exerts not only reversible but also irreversible damages,
leading to a signiﬁcant decrease of viable cells from both Candida
species populations. Moreover, it is also important to highlight that
despite cell integrity loss, some Candida cells remain cultivable. The
most signiﬁcant reduction was observed to C. glabrata ATCC 2001,
where no cultivable cells were detectable at 60 min-treatment with a
reduction of approximately 7 orders of magnitude. On the other hand, a
reduction of 1.8 orders of magnitude was observed, from 0 to 60 min of
treatment of C. albicans ATCC 90028. Thus, taking it account these
ﬁndings, it is possible to conﬁrm that licorice extract presents a marked
ability to exert irreversible cellular damages in both Candida strains
tested.
On the other hand, and despite the scarcity of studies reporting the
mechanism of action of licorice extract against Candida species, through
the present study it was expected that licorice lead to microorganisms’
toxicity and consequent unviability by primary cellular membrane da-
mages. In fact, it was already reported that licorice extracts mainly acts
by inhibition of enzymatic activity and consequent establishment of
non-speciﬁc interactions with membrane proteins (Sher, 2009). More-
over, and not least interesting to emphasize is that Wyk et al., 2009
observed that the antifungal activity evidenced by licorice extracts
against C. albicans was mainly conferred by ﬂavonoids and iso-
ﬂavonoids, which act in a synergistic manner with the other bioactive
compounds presents in the samples (Jatav et al., 2011; Wyk et al.,
2009), being this aspect in agreement with the results obtained in the
present study.
Nevertheless, taking into account the advances reached in the last
years, the number of studies assessing the type of morphological
changes occurred in Candida cells still continue being scarce (Martins
et al., 2015b,c). Thus, aiming to clarify the type of morphological cel-
lular damages occurred in Candida cells, microscopic analyses using
TEM were carried out, being the obtained results presented in Fig. 2B.
The micrographs of the internal morphology of licorice treated C. al-
bicans (Fig. 2I B) and C. glabrata (Fig. 2II B) cells conﬁrms the hy-
pothesis of the dramatic changes at 30 min of treatment, with the cy-
toplasmic disorganization coupled with notable alterations in the
cytoplasmic membrane size and structure resulting in evident in-
vaginations (see arrows). It is also important to highlight the increased
of the cell membrane thickness from to 217 ± 1.9 nm up to
275 ± 4.4 nm, and from to 182 ± 1.9 nm up to 242 ± 2.3 nm in
case of C. albicans andC. glabrata respectively, after licorice application.
The results suggest that the plant extract induced dysfunctions on the
cell membrane and consequently, the cell lost its metabolic functions
leading to viability lost as proved by the cultivability assays after
60 min (Fig. 2A).
Finally, the assessment of the cytotoxic potential of licorice extract
was also performed using liver tissues. Interestingly, licorice extract
exerts neither toxic eﬀects nor morphological changes up to a con-
centration of 1.5 mg/mL (data not shown). Therefore, licorice seems to
be an upcoming eﬀective, eﬃcient and safer anti-Candida drug.
4. Conclusion
Overall, licorice methanol: water extract exerts a prominent candi-
dacidal eﬀect, being this pronounced eﬀect observable both in C. albi-
cans and C. glabrata strains, which means that licorice extract acts ef-
ﬁciently in a non-selective manner.
Flow Cytometry and TEM observations revealed that this extract
causes fast and irreversible damages to the cell walls of both Candida
species. Moreover, it was also shown that this extract is non-toxic to
liver tissues. Based on this ﬁndings licorice extract may be considered
Fig. 2. Eﬀect of licorice methanol: water extract on
Candida albicans ATCC 90028 (I) and Candida glab-
rata ATCC 2001 (II) cells. A) Logarithm of reduction
of colony forming units (CFUs) and B) Morphological
cells changes evaluated by transmission electron
microscopy (TEM). Error bars represent standard
deviations (SD). Statistical p value (represented by *)
indicates concentrations that are signiﬁcantly dif-
ferent from control. *p < 0.05. M corresponds to
mitochondria; CW corresponds to cell wall; CM cor-
responds to cellular membrane and V corresponds to
vacuole. Arrows evidenced the presence of cell
membrane invaginations.
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as promising anti-yeast agent, exerting fast and irreversible primary
cellular damages both in C. glabrata and C. albicans cells, being those
eﬀects non-time-dependent.
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